Searched for
BOSTON SCIENTIFIC CORPORATION
US stocks today: S&P, Nasdaq close at records on Iran ceasefire extension, earningsU.S. stocks rallied Wednesday, snapping a two-day decline, as President Trump extended a ceasefire with Iran. Despite ongoing uncertainty a...- Why are US stock market futures up today, and will S&P 500, Dow Jones and Nasdaq stay in green or turn red again? Wall Street futures, stocks to watch, analysts insights, investor guide and market outlookWhy are US stock market futures up today, and will S&P 500, Dow Jones and Nasdaq stay in green or turn red again? US stock futures moved hi...
- H-1B visa holders don't just fill existing positions but create new economic ecosystems: IndiasporaIndiaspora highlights the H-1B program's crucial role in attracting global talent and fostering economic growth in the US. Despite concerns...
- Who is Anurag Bajpayee? Lucknow-educated MIT scientist and CEO linked to alleged Cambridge sex scandalAnurag Bajpayee, the Indian-origin CEO of water-tech firm Gradiant, has been linked with a high-profile brothel investigation near Harvard ...
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate resultsTesla jumped 12% after the electric vehicle maker's plans to boost production and roll out more affordable models overshadowed its weak qua...
- Boston Scientific to buy Apollo Endosurgery for $417 millionThe offer of $10 per share in cash for Apollo Endosurgery represents a premium of nearly 67% to the stock's last close. Its shares were up ...
- Analysis: Twitter has legal edge in deal dispute with Elon MuskElon Musk's main claim against Twitter is that the San Francisco-based company breached their deal because it will not share with him enoug...
- Titan appoints Ashok Sonthalia as chief financial officerThe company also announced the appointment of Swadesh Behera as the chief people officer of the company
- Titan Company onboards new Chief People Officer, Swadesh BeheraBehera is a seasoned HR leader whose areas of expertise include building a robust a leadership pipeline, developing top talent, cogent succ...
- Everstone picks up minority stake in stent company TransluminaDeal worth Rs 500 crore to help Indian stent maker acquire global assets, boost R&D efforts
- USIBC forms India Advisory Council to enhance bilateral tiesIndia Advisory Council is a group of India-based leaders of American and Indian cos that "play an important role in helping create that str...
- Boston Scientific appoints Warren Wang as new president of Asia Pacific regionWang will serve as a member of the Boston Scientific executive committee and be responsible for overseeing the company’s continued growth i...
- Indian Institute of Foreign Trade concludes summer placementsAround 80 recruiters made offers to the batch of 282 students. Companies hired students aggressively and 16 companies recruited more than f...
- Three MNC pharma companies want to recall its new generation stents from IndiaIt's not clear if firms can withdraw their products as the Department of Pharmaceuticals had recently prevented stent makers from taking th...
- Amit Lakhotia, VP of payments at Paytm quitsAmit Lakhotia, vice president of payments at Paytm, has quit to take a break and pursue other interests.
- Paytm brings ITC executive Varun Khullar on boardMobile payments and ecommerce firm Paytm has appointed former Boston Scientific Corporation and ITC executive Varun Khullar as the head of ...
- Top US, Indian CEOs like Cyrus Mistry, Anil Ambani, Mary Barra, others converge in WashingtonThe forum also has four Indian-American CEOs Ajay Banga, Sanjay Bhatnagar, Shantanu Narayen, Indra Nooyi and Dinesh Paliwal.
- XLRI Jamshedpur places its summer interns in a record time of three and a half daysThe top 5 recruiters on campus in terms of number of offers made were Vodafone, Microsoft, ITC, TAS and Standard Chartered.
- NRI scientists who turned research into successful businessesNot many Indians in US would risk turning their scientific research into successful businesses. Here is the story of the bravehearts who di...
- Rivals to benefit as J&J exits from heart stentsThe decision of Johnson&Johnson to stop making its popular drug eluting stent has opened up new opportunities for competitors Abbott & Bost...
Load More
